News

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...
Shivarajkumar had confirmed that his almost year-long battle with bladder cancer would be documented for public awareness ...
ImmunityBio’s ANKTIVA shows promise, but modest growth, high cash burn, and rising competition raise red flags. Read why IBRX stock is a sell.
Discover a study comparing ultrasound and CBCT for bladder monitoring in prostate cancer radiotherapy to improve accuracy and ...
Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...
King Charles and his daughter-in-law Kate's public battles with cancer have had a huge impact on fellow sufferers, ...
Two local families are trying to raise $12,000 for the American Cancer Society by September, and they’re hoping your knowledge of Disney will help them do it. Gray Augustus, Dusty Bee and both of ...
The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...
DNA profiling can help stratify risk of recurrence in patients with BCG-unresponsive NMIBC treated with atezolizumab. Read ...
Drinking water treatment that pursues a multi-contaminant approach, tackling several pollutants at once, could prevent more ...
Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for to help catch it before it ...